Form 4: Morgan Stanley CFO Sells Shares Under 10b5-1 Plan

Morgan Stanley's Chief Financial Officer, Sharon Yeshaya, sold 15,838 shares of common stock for approximately $2.94 million under a pre-arranged plan.

Summary

• Sharon Yeshaya, Chief Financial Officer of Morgan Stanley, reported the sale of 15,838 shares of Morgan Stanley common stock.
• The transaction occurred on January 20, 2026, and was executed under a Rule 10b5-1(c) plan.
• The shares were sold at a weighted average price of $185.7669 per share, with individual transaction prices ranging from $185.67 to $185.98.
• The total value of the shares sold amounts to approximately $2,941,100.
• Following this transaction, Sharon Yeshaya beneficially owns 135,304.336 shares of Morgan Stanley common stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction report (Form 4) under a pre-arranged 10b5-1 plan, which typically has a neutral impact on sentiment as it's not indicative of new company performance or strategic shifts.

Positives

• The sale was conducted pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary transaction designed to comply with insider trading rules.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market, though this is a common occurrence for executive compensation and liquidity management.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it is a report of an insider transaction.

Industry Context

Insider transactions, particularly sales under Rule 10b5-1 plans, are common across the financial services industry for executive compensation and personal financial planning. This transaction by Morgan Stanley's CFO is consistent with typical executive stock management practices.

Comparison to Industry Standards

• Insider sales under Rule 10b5-1 plans are a standard practice for executives in large financial institutions like JPMorgan Chase, Goldman Sachs, and Bank of America, allowing them to diversify holdings and manage liquidity in a pre-scheduled, compliant manner.
• The volume of shares sold by the CFO is a relatively small percentage of the company's total outstanding shares, which is typical for individual executive transactions and generally does not signal a significant change in company fundamentals.

Stakeholder Impact

• Shareholders: The sale represents a minor adjustment in the CFO's direct ownership, but the overall impact on the company's stock structure or market perception is generally minimal given it's a pre-planned transaction.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-scheduled insider sale by Morgan Stanley's CFO under a 10b5-1 plan. Such transactions are common for executive compensation and personal financial management and typically do not reflect a change in the company's fundamental outlook or performance. Therefore, it does not provide new information that would warrant a change from a 'hold' recommendation based solely on this filing.

Keywords

Morgan Stanley, MS, Sharon Yeshaya, CFO, Insider Sale, Form 4, Stock Transaction, Equity, 10b5-1 Plan